The rats were also quicker to return to their everyday behaviours than the ones that did not get the enzyme-blocking drugs, shows the study, published in the journal Science Translational Medicine.
The new class of drugs - DFSAs - permanently bind to the enzyme, blocking its action and stopping it from spreading further, the journal Science reported.